Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 11;30(5):660-674.
doi: 10.1016/j.chom.2022.04.007.

Maternal immune protection against infectious diseases

Affiliations
Free article
Review

Maternal immune protection against infectious diseases

Stephanie N Langel et al. Cell Host Microbe. .
Free article

Abstract

The maternal immune system protects developing offspring against pathogens before birth via transplacental transfer and after birth through secreted milk. This transferred maternal immunity influences each generation's susceptibility to infections and responsiveness to immunization. Thus, boosting immunity in the maternal-neonatal dyad is a potentially valuable public health strategy. Additionally, at critical times during fetal and postnatal development, environmental factors and immune stimuli influence immune development. These "windows of opportunity" offer a chance to identify both risk and protective factors that promote long-term health and limit disease. Here, we review pre- and postpartum maternal immune factors that protect against infectious agents in offspring and how they may shape the infant's immune landscape over time. Additionally, we discuss the influence of maternal immunity on the responsiveness to immunization in early life. Lastly, when maternal factors are insufficient to prevent neonatal infectious diseases, we discuss pre- and postnatal therapeutic strategies for the maternal-neonatal dyad.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.R.P. provides consulting services to Moderna, Merck, Pfizer, Dynavax, and Hoopkia related to CMV vaccines and participates in sponsored research programs with Merck and Moderna. The authors have declared that no conflict of interest exists.

Similar articles

Cited by

Substances

LinkOut - more resources